Patanase approved for seasonal allergies

Patanase available for seasonal allergies
Patanase available for seasonal allergies
The FDA has approved Patanase (olopatadine hydrochloride nasal spray, from Alcon) for the relief of seasonal allergic rhinitis in patients ≥12 years of age. This approval is supported by multiple double-blind clinical trials that showed significant decreases in nasal allergy symptoms in Patanase-treated patients compared to placebo. Alcon expects Patanase to be available by May 2008.

For more information call (800) 757-9195 or visit www.patanase.com.